ASH : Study Suggests Maintenance Role for Novel Factor Xa Inhibitor .

Results from a randomized, placebo-controlled trial in patients with a history of venous thromboembolic events suggest a benefit for maintenance therapy with rivaroxaban, an investigational oral selective Factor Xa inhibitor.
...